Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04751461 · ClinicalTrials.gov registry record · NA
CSD210202: A Study to Assess Nicotine Uptake From Electronic Nicotine Delivery Systems
A NA study, sponsored by RAI Services Company.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT04751461 is a NA study that has completed, run by RAI Services Company. The registered enrollment target is 33 participants.
The verdict
NCT04751461, a NA study, has completed, sponsored by RAI Services Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
This is an open-label, randomized, 5-way crossover study designed to evaluate plasma nicotine pharmacokinetic (PK) parameters following an ad libitum use of Electronic Nicotine Delivery System (ENDS) investigational products (IPs) in a confinement setting by generally healthy combustible cigarette (CC) smokers.
Interventions
- OTHER Product A
- OTHER Product B
- OTHER Product C
- OTHER Product D
- OTHER Product E
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2021-02-23 |
| Est. Completion | 2021-04-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04751461
The ClinicalTrials.gov registry entry for NCT04751461 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is RAI Services Company, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Product A is the first listed.
NCT04751461 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04751461 about?
NCT04751461 is a clinical study titled "CSD210202: A Study to Assess Nicotine Uptake From Electronic Nicotine Delivery Systems". This is an open-label, randomized, 5-way crossover study designed to evaluate plasma nicotine pharmacokinetic (PK) parameters following an ad libitum use of Electronic Nicotine Delivery System (ENDS) investigational products (IPs) in a confinement setting by generally healthy combustible cigarette (...
What is the current status of trial NCT04751461?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2021-02-23. Estimated completion is 2021-04-20.
What interventions are being tested in trial NCT04751461?
The interventions under investigation include: Product A (OTHER), Product B (OTHER), Product C (OTHER), Product D (OTHER), Product E (OTHER).
Who is sponsoring clinical trial NCT04751461?
This trial is sponsored by RAI Services Company, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.